CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Cost of Revenue
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Cost of Revenue of $660.74 million for the 3-month period ending 2024-09-28, per its 10-Q filed 2024-11-06.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2024-11-06
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. cost of goods and services sold for the quarter ending 2024-09-28 was $660.74M, a 0.61% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. cost of goods and services sold for the quarter ending 2024-06-29 was $672.40M, a 1.73% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. cost of goods and services sold for the quarter ending 2024-03-30 was $666.72M, a 2.30% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. cost of goods and services sold for the quarter ending 2023-09-30 was $664.78M.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month |
|---|---|---|---|
| 2024-09-28 | $660.74M 10-Q · filed 2024-11-06 | $1.33B derived: sum of 2 quarters · filed 2024-11-06 | $2.00B 10-Q · filed 2024-11-06 |
| 2024-06-29 | $672.40M 10-Q · filed 2024-08-07 | $1.34B 10-Q · filed 2024-08-07 | |
| 2024-03-30 | $666.72M 10-Q · filed 2024-05-09 | ||
| 2023-09-30 | $664.78M 10-Q · filed 2024-11-06 | $1.33B derived: sum of 2 quarters · filed 2024-11-06 | $1.98B 10-Q · filed 2024-11-06 |
| 2023-07-01 | $660.96M 10-Q · filed 2024-08-07 | $1.31B 10-Q · filed 2024-08-07 | |
| 2023-04-01 | $651.72M 10-Q · filed 2024-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |